R68070, a combined thromboxane/endoperoxide receptor antagonist and thromboxane synthase inhibitors, inhibits human platelet activation in vitro and in vivo: a comparison with aspirin - Hoet, B; Falcon, C; De Reys, C; Arnout, J; Deckmyn, H; Vermylen, J (Blood, 1990)